Cunha-Filho Marcílio S S, Dacunha-Marinho Bruno, Torres-Labandeira Juan J, Martínez-Pacheco Ramón, Landín Mariana
Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, 15782, Spain.
AAPS PharmSciTech. 2007 Jul 27;8(3):E60. doi: 10.1208/pt0803060.
The purpose of this research was to explore the utility of beta cyclodextrin (betaCD) and beta cyclodextrin derivatives (hydroxypropyl-beta-cyclodextrin [HPbetaCD], sulfobutylether-beta-CD [SBbetaCD], and a randomly methylated-beta-CD [RMbetaCD]) to form inclusion complexes with the antitumoral drug, beta-lapachone (betaLAP), in order to overcome the problem of its poor water solubility. RMbetaCD presented the highest efficiency for betaLAP solubilization and was selected to develop solid-state binary systems. Differential scanning calorimetry (DSC), X-ray powder diffractometry (XRPD), Fourier transform infrared (FTIR) and optical and scanning electron microscopy results suggest the formation of inclusion complexes by both freeze-drying and kneading techniques with a dramatic improvement in drug dissolution efficiency at 20-minute dissolution efficiency (DE(20-minute) 67.15% and 88.22%, respectively) against the drug (DE(20-minute) 27.11%) or the betaCD/drug physical mixture (DE(20-minute) 27.22%). However, the kneading method gives a highly crystalline material that together with the adequate drug dissolution profile make it the best procedure in obtaining inclusion complexes of RMbetaCD/betaLAP convenient for different applications of betaLAP.
本研究的目的是探索β-环糊精(βCD)及其衍生物(羟丙基-β-环糊精[HPβCD]、磺丁基醚-β-环糊精[SBβCD]和随机甲基化-β-环糊精[RMβCD])与抗肿瘤药物β-拉帕醌(βLAP)形成包合物的效用,以克服其水溶性差的问题。RMβCD对βLAP的增溶效率最高,因此被选用于开发固态二元体系。差示扫描量热法(DSC)、X射线粉末衍射法(XRPD)、傅里叶变换红外光谱法(FTIR)以及光学和扫描电子显微镜结果表明,通过冷冻干燥和捏合技术均形成了包合物,与药物(20分钟溶出效率[DE(20分钟)]为27.11%)或βCD/药物物理混合物(DE(20分钟)为27.22%)相比,药物溶出效率有显著提高(20分钟溶出效率分别为67.15%和88.22%)。然而,捏合方法得到的材料结晶度很高,再加上适当的药物溶出曲线,使其成为获得适用于βLAP不同应用的RMβCD/βLAP包合物的最佳方法。